$4.57
1.11%
Nasdaq, Dec 26, 10:00 pm CET
ISIN
US0088751062
Symbol
DOMH

AIkido Pharma Inc Stock price

$4.57
-0.10 2.14% 1M
-1.11 19.59% 6M
+3.66 401.48% YTD
+3.42 298.12% 1Y
+1.49 48.25% 3Y
-6.88 60.10% 5Y
-162.80 97.27% 10Y
-813,260.23 100.00% 20Y
Nasdaq, Closing price Fri, Dec 26 2025
+0.05 1.11%
ISIN
US0088751062
Symbol
DOMH
Industry

Key metrics

Basic
Market capitalization
$73.2m
Enterprise Value
$-103.0m
Net debt
positive
Cash
$176.2m
Shares outstanding
15.8m
Valuation (TTM | estimate)
P/E
0.7 | -
P/S
0.7 | -
EV/Sales
negative | -
EV/FCF
14.2
P/B
0.4
Financial Health
Equity Ratio
84.6%
Return on Equity
-36.9%
ROCE
-25.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$99.6m | -
EBITDA
$-55.7m | -
EBIT
$-55.8m | -
Net Income
$110.4m | -
Free Cash Flow
$-7.3m
Growth (TTM | estimate)
Revenue
691.0% | -
EBITDA
-284.8% | -
EBIT
-282.8% | -
Net Income
586.6% | -
Free Cash Flow
56.4%
Margin (TTM | estimate)
Gross
-
EBITDA
-56.0% | -
EBIT
-56.1%
Net
110.9% | -
Free Cash Flow
-7.3%
More
EPS
$6.4
FCF per Share
$-0.5
Short interest
6.2%
Employees
29
Rev per Employee
$630.0k
Show more

Is AIkido Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

AIkido Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from AIkido Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
100 100
691% 691%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 155 155
472% 472%
156%
- Research and Development Expense - -
-
-
-56 -56
285% 285%
-56%
- Depreciation and Amortization 0.10 0.10
0% 0%
0%
EBIT (Operating Income) EBIT -56 -56
283% 283%
-56%
Net Profit 110 110
587% 587%
111%

In millions USD.

Don't miss a Thing! We will send you all news about AIkido Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AIkido Pharma Inc Stock News

Neutral
PRNewsWire
16 days ago
NEW YORK , Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce that, following its press release issued on December 11, 2025, the board of directors has updated the record date and payment date for the previously announced special cash dividend of approximately $10 million, or approximately $0.44 per share. The dividend is now payable on or about January 2...
Neutral
PRNewsWire
17 days ago
NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $10 million, or approximately $0.44 per share.  The dividend is payable on or about January 23, 2026, to DOMH's common stock shareholders and certain DOMH warrant holders (on an as-exercised b...
Neutral
PRNewsWire
20 days ago
Dominari Withdraws $2 Billion Shelf Registration NEW YORK , Dec. 8, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) today announced a major enhancement to its strategic leadership with the appointment of Ambassador Jamie McCourt to the Advisory Board of Dominari Securities. Separately, the company has formally withdrawn its previously filed $2 billion shelf registration statement, re...
More AIkido Pharma Inc News

Company Profile

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

Head office United States
CEO Anthony Hayes
Employees 29
Founded 1967
Website www.dominariholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today